With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Novel study by researchers at the Rambam Health Care Campus could help 21 million people worldwide suffering from the severe ...

An experimental brain implant can capture the signals of movement-related brain regions while Parkinson’s patients perform daily activities like walking to the kitchen or strolling through a park, ...

Through Nexalin America, the Company’s division dedicated to U.S. government engagement, the Company participated in advocacy ...

A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don't respond to medication and aren't candidates for surgery. Their approach, ...

A new study suggests that a promising noninvasive brain stimulation technique may not function exactly as psychiatrists had ...

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...

UAB researchers are involved in a new clinical trial to explore a promising treatment for adults suffering from major depressive disorder, especially for those who have not been successfully treated ...